H2O Innovation announces $6.5 million of new contracts in the oil & gas industry

News - Amongst the contracts announced today, two of them are major contracts awarded by a leading independent energy company engaged in the exploration, development and production of natural gas and oil in North America. These two contracts will see H2O Innovation design, build and commission a potable water treatment package as well as a wastewater treatment package for a 2,300 person workers camp in Northern Alberta.

WANTED Technologies Corporation announces the signature of a material contract

News - WANTED Technologies Corporation (the "Corporation") (TSXV: WAN) announces that it has entered into a twelve-month data license agreement having a value of $1,080,000, $900,000 of which constitutes non-recurring revenue.

Strongco Opens New Larger Facility in Quebec City

News - Strongco Corporation is pleased to announce the grand opening of its newest location in Saint-Augustin-de-Desmaures, a suburb of Quebec City. Strongco has invested $8.6 million in the new facility to replace its old branch in Sainte-Foy, better positioning the company as a leader in the Quebec region. On eight acres, the new 40,500 square foot facility, with 10 service bays, will significantly increase the company's capacity to service the market. The new facility will employ approximately 40 people, including 15 highly trained technicians.

Université Laval and Roche team up to test promising compounds for several disorders of the brain, including autism spectrum disorders

News - Thanks to this joint initiative, Université Laval researcher Yves De Koninck and his team will be able to pursue the development of the many scientific discoveries and advances they have made in the last 10 years. Dr. De Koninck is a Professor in Université Laval’s Faculty of Medicine, Scientific Director of the Institut Universitaire en Santé Mentale de Québec, and an internationally renowned expert in the fields of neurology and neurophotonics.

Inaugural promotional event for YQB - Québec City launches its new regional sales force

News - Québec City now has a regional sales force to promote business tourism outside the province. Unveiled this morning at the Québec City Convention Centre, YQB (Your Québec City Business Destination) will be on the job with the goal of significantly increasing room-nights in the Québec City area. This dream team was created in fall 2013, shepherded by a strategic committee of movers and shakers assembling out-of-province business tourism specialists from Québec City Tourism, the Québec City Convention Centre, and ExpoCité's Centre de foires to help unify, standardize and increase the effectiveness of the city's sales and promotions.

Archaeology shines at Québec City Convention Centre

News - The 47th Conference on Historical and Underwater Archaeology opened January 8 at the Québec City Convention Centre. More than 1,000 attendees from 40 countries, mainly the United States and Canada, will attend the conference organized by the Society for Historical Archaeology, a Washington-based international organization.

Canada courting U.S. web giants in wake of NSA spy scandal

News - “There’s a real tendency, especially among foreigners like European companies operating in the United States,” said Martin Bouchard, a principal with 4Degrés, a Quebec City data centre that is opening for business in March.

Optosecurity: Finavia to deploy OptoScreener for LEDs in preparation for partial lifting of EU liquids ban

News - Optosecurity, a leader in liquid explosives detection (LED) and operation productivity software, announced today that it has received a significant order for its LED and Firearm Detection product, OptoScreener, from Finnish Airport Operator, Finavia. The announcement comes on the heels of a number of new Standard 2 ECAC certifications the company was recently awarded.

Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific Officer

News - Aeterna Zentaris announced the appointment of Richard Sachse, MD, PhD, as Senior Vice President, Chief Scientific Officer. Before joining Aeterna Zentaris, Dr. Sachse was Vice President, Head of Global Translational Medicine at Boehringer Ingelheim.

Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA

News - Aeterna Zentaris today announced that the U.S. Food and Drug Administration has accepted for filing the Company's New Drug Application for its ghrelin agonist, macimorelin acetate, in Adult Growth Hormone Deficiency. The acceptance for filing of the NDA indicates the FDA has determined that the application is sufficiently complete to permit a substantive review.


Subscribe to our newsletter for interesting news and information.

Print this page